AIP4 |
Stabilizing the complex between ALK5 and Smad7 and inhibiting TGF-β signaling |
[19] |
Arkadia |
Degradation of Smad7 |
[20] |
Axin |
An adaptor between Smad7 and Arkadia |
[21] |
Cas-L (Crk-associated substrate lymphocyte type) |
Facilitating TGF-β signaling by interfering with the inhibitory effect of Smad7 |
[26] |
FKBP12 |
An adaptor between ALK5 and Smad7–Smurf1 |
[27] |
GADD34-PP1c |
Dephosphorylation of ALK5 |
[16] |
HDACs |
Deacetylation of Smad7 and inhibition of TGF-β signaling |
[34,35] |
Hic-5/ARA55 |
Degradation of Smad7 |
[23] |
Jab1/CSN5 |
Degradation of Smad7 |
[22] |
Nedd4-2 |
Degradation of the type I receptors, R-Smads and Smad4 |
[14] |
p300/CBP |
Acetylation and stabilization of Smad7 |
[34,35] |
Phosphatase 1α |
Dephosphorylation of ALK1 |
[17] |
SIK (the salt-inducible kinase) |
Degradation of TβRI |
[25] |
SIRT1 |
Deacetylation of Smad7 and inhibition of TGF-β signaling |
[33] |
Smurf1/2 |
Degradation of the type I receptors, R-Smads, Smad4 and Smad7 |
[14] |
STRAP |
Stabilizing the complex between ALK5 and Smad7 and inhibiting TGF-β signaling |
[18] |
TRAFs; TAK1 |
Activation of p38 MAPK signaling pathway by TGF-β with Smad7 as an adaptor; inhibition of NF-κB signaling by dissembling the TRAF–TAK1–TAB2/3 complex via Smad7 |
[12,42,80] |
Yes-associated protein (YAP65) |
facilitating the recruitment of Smad7 to activated TβRI |
[24] |
WWP1/Tiul1 |
Degradation of the type I receptors, R-Smads and Smad4 |
[14] |